dual Pgp/MRP1 inhibitors (Xenova)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual Pgp/MRP1 inhibitors (Xenova)
Drug Alias NameQuinazolinones
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAnticancer multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXenova
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXenova
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A